Skip to main content

Find Clinical Trials

Home
Conditions
Solid Tumors With FGFR2 Alterations, Adult

Clinical trial condition

Solid Tumors With FGFR2 Alterations, Adult

Explore clinical trials studying Solid Tumors With FGFR2 Alterations, Adult. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Solid Tumors With FGFR2 Alterations, Adult trial results

Recruiting

A Study of 3HP-2827 in Treatment of Unresectable or Metastatic Solid Tumors With FGFR2 Alterations

NCT06378593

Conditions: Solid Tumors With FGFR2 Alterations, Adult
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

ZhongShan Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations

NCT06287918

Conditions: Solid Tumors With FGFR2 Alterations, Adult
Locations: Mayo Clinic Phoenix, Arizona, United States

The University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

A Study of KNT-0916 in Treatment of Unresectable or Metastatic Solid Tumors with FGFR2 Alterations

NCT06800196

Conditions: Solid Tumors With FGFR2 Alterations, Adult
Locations: Not specified

View Trial Details